title: [Multi-central randomized controlled study on electroacupuncture at Fenglong (ST 40) for regulating blood lipids].
abstract: OBJECTIVE
  To investigate the clinical effects of electroacupuncture (EA) at Fenglong (ST 40) on blood lipids.
  
  
  METHODS
  Two hundred and four patients of hyperlipidemia were randomly divided into a Fenglong group and a Xuezhikang group, 102 cases in each group. The patients in the Fenglong group were treated with electroacupuncture at Fenglong (ST 40). After arrival of qi, the needles were connected with acupoint nerve stimulator (LH 202 H type, HANS). The primary parameters of EA: for high triglycerides (TG) type, AM 50 Hz, intensity 1 mA, needle-retained time 20 min, twice per week; for high cholesterol (CHO) type, AM 100 Hz, intensity 1 mA, needle-retained time 30 min, thrice per week; for high low-density-lipoprotein (LDL-C) type, the same parameters as the high CHO type except the tolerable and comfortable intensity; for the mixing type, corresponding methods were alternatively used. The patients in the Xuezhikang group received Xuezhikang capsule orally, 2 capsules each time and twice daily, for total 11 weeks.
  
  
  RESULTS
  The total effective rates of the Fenglong group and the Xuezhi-kang group were 83.0% and 85.9%, respectively, with no significant difference between the two groups (P > 0.05), and there was no significant differences in the function of regulating blood lipids between the two groups (all P > 0.05). After one month follow-up survey, the total CHO, TG and LDL-C decreased and high-density-lipoprotein (HDL-C) increased, of which there was a significant difference in TG reduction (P < 0.05). There were no relapses in both groups.
  
  
  CONCLUSIONS
  EA at Fenglong (ST 40) can effectively regulate blood lipids with a better after-effect, which can be applied as a safe and effective method to replace medication for regulating blood lipids.
authors.affiliation: Acupuncture College of Beijing University of CM, Beijing 100029, China. xiejieping@sina.com
authors.forename: Jie-ping
authors.initials: JP
authors.lastname: Xie
authors.forename: Gui-ling
authors.initials: GL
authors.lastname: Liu
authors.forename: Jin-lin
authors.initials: JL
authors.lastname: Qiao
authors.forename: Qun
authors.initials: Q
authors.lastname: Gu
authors.forename: Ya-nan
authors.initials: YN
authors.lastname: Gai
authors.forename: Shu-fang
authors.initials: SF
authors.lastname: Huang
authors.forename: Ai-ai
authors.initials: AA
authors.lastname: Gao
authors.forename: Yi
authors.initials: Y
authors.lastname: Zhou
authors.forename: Xiao-hong
authors.initials: XH
authors.lastname: Li
authors.forename: Chao-yang
authors.initials: CY
authors.lastname: Wang
authors.forename: Ren-quan
authors.initials: RQ
authors.lastname: Liu
authors.forename: Jun-jun
authors.initials: JJ
authors.lastname: Jia
mesh_terms: D015669:Acupuncture Points; D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D015671:Electroacupuncture; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000628:therapy*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
chemical_list: D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol